VERAPAMIL

Course overview

THE FOOD AND DRUG ADMINISTRATION (FDA) APPROVED INDICATIONS FOR VERAPAMIL INCLUDE ANGINA (CHRONIC STABLE, VASOSPASTIC OR PRINZMETAL VARIANT), UNSTABLE ANGINA (CRESCENDO, PREINFARCTION), HYPERTENSION AS ADD-ON THERAPY, PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT) PROPHYLAXIS, AND SUPRAVENTRICULAR TACHYCARDIA (SVT). VERAPAMIL ALSO HAS NUMEROUS NON-FDA-APPROVED INDICATIONS. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISM OF ACTION, ADMINISTRATION METHODS, SIGNIFICANT ADVERSE EFFECTS, CONTRAINDICATIONS, TOXICITY, AND MONITORING, OF VERAPAMIL SO PROVIDERS CAN DIRECT PATIENT THERAPY WHERE IT IS INDICATED AS PART OF THE INTERPROFESSIONAL TEAM.